1,7-Annulated indolocarbazoles as cyclin-dependent kinase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 12, 2004, Pages 3217-3220

  Al Awar, Rima S ^a   Ray, James E ^a   Hecker, Kyle A ^a   Huang, Jianping ^a   Waid, Philip P ^a   Shih, Chuan ^a   Brooks, Harold B ^a   Spencer, Charles D ^a   Watkins, Scott A ^a   Patel, Bharvin R ^a   Stamm, Nancy B ^a   Ogg, Catherine A ^a   Schultz, Richard M ^a   Considine, Eileen L ^a   Faul, Margaret M ^a   Sullivan, Kevin A ^a   Kolis, Stanley P ^a   Grutsch, John L ^a   Joseph, Sajan ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBAZOLE DERIVATIVE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; INDOLE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL;

CARBAZOLES; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; INDOLES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS;

EID: 2442471732     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.03.105     Document Type: Article

References (32)

1. Rao N.R. Curr. Opin. Oncol. 8:1996;516
2. Lingfei K., Pingzhang Y., Zhengguo L., Jianhua G., Yaowu Z. Cancer Lett. 130:1998;93
3. Toogood P.L. Curr. Opin. Chem. Biol. 6:2002;472
4. Fischer L., Endicott J., Meijer L. Progr. Cell Cycle Res. 5:2003;235
5. Monaco E.A. 3rd, Vallano M.L. Curr. Med. Chem. 10:2003;367
6. Hardcastle I.R., Golding B.T., Griffin R.J. Annu. Rev. Pharmacol. Toxicol. 42:2002;325
7. Knockaert M., Greengard P., Meijer L. Trends Pharmacol. Sci. 23:2002;417
8. Tan A.R., Swain S.M. Seminars Oncol. 29:2002;77
9. Filgueira de Azevedo W. Jr., Canduri F., Freitas da Silveira N.J. Biochem. Biophys. Res. Commun. 293:2002;566
10. Gussio R., Zaharevitz D.W., McGrath C.F., Pattabiraman N., Kellogg G.E., Schultz C., Link A., Kunick C., Leost M., Meijer L., Sausville E.A. Anti-Cancer Drug Des. 15:2000;53
11. Zaharevitz D.W., Gussio R., Leost M., Senderowicz A.M., Lahusen T., Kunick C., Meijer L., Sausville E.A. Cancer Res. 59:1999;2566
12. Haesslein J.-L., Jullian N. Curr. Top. Med. Chem. 2:2002;1037
13. Legraverend M., Ludwig O., Leclerc S., Meijer L. J. Heterocycl. Chem. 38:2001;299
14. Jackson J.R., Gilmartin A., Imburgia C., Winkler J.D., Marshall L.A., Roshak A. Cancer Res. 60:2000;566
15. Gilmartin, A. G.; Ho, M. L.; Imburgia, C. S.; Roshak, A. K.; Lago, M. A. WO 0016781 A1 20000330, 2000
16. Kleinschroth, J.; Schaechtele, C.; Hartenstein, J.; Rudolph, C. Eur. Patent 410389 A1 19910130, 1991
17. Sampath D., Shi Z., Plunkett W. Mol. Pharmacol. 62:2002;680
18. Johnson L.N., De Moliner E., Brown N.R., Song H., Barford D., Endicott J.A., Noble M.E.M. Pharmacol. Therap. 93:2002;113
19. Merchant J., Tutsch K., Dresen A., Arzoomanian R., Alberti D., Feierabend C., Binger K., Marnoccha R., Thomas J., Cleary J., Wilding G. Clin. Cancer Res. 8:2002;2193
20. Long B.H., Rose W.C., Vyas D.M., Matson J.A., Forenza S. Curr. Med. Chem.: Anti-Cancer Agent. 2:2002;255
21. Carrasco C., Vezin H., Wilson W.D., Ren J., Chaires J.B., Bailly C. Anti-Cancer Drug Des. 16:2001;99
22. Tolcher A.W., Eckhardt S.G., Kuhn J., Hammond L., Weiss G., Rizzo J., Aylesworth C., Hidalgo M., Patnaik A., Schwartz G., Felton S., Campbell E., Rowinsky E.K. J. Clin. Oncol. 19:2001;2937
23. Senderowicz A.M. Oncogene. 19:2000;6600
24. Zhu G., Conner S.E., Zhou X., Shih C., Li T., Anderson B.D., Brooks H.B., Campbell R.M., Considine E., Dempsey J.A., Faul M.M., Ogg C., Patel B., Schultz R.M., Spencer C.D., Teicher B., Watkins S.A. J. Med. Chem. 46:2003;2027
25. Zhu G., Conner S., Zhou X., Shih C., Brooks H.B., Considine E., Dempsey J.A., Ogg C., Patel B., Schultz R.M., Spencer C.D., Teicher B., Watkins S.A. Bioorg. Med. Chem. Lett. 13:2003;1231
26. Faul M.M., Winneroski L.L., Krumrich C.A. Tetrahedron Lett. 40:1999;1109
27. Faul M.M., Winneroski L.L., Krumrich C.A. J. Org. Chem. 63:1998;6053
28. Paudler W.W., Shin H.G. J. Heterocycl. Chem. 6:1969;415
29. van Wijngaarden I., Hamminga D., van Hes R., Standaar P.J., Tipker J., Tulp M.T.M., Mol F., Olivier B., de Jonge A. J. Med. Chem. 36:1993;3693
30. Neiduzak T.R., Boyer F.E. Synth. Commun. 26:1996;3443
31. 4, protection of the resulting alcohol as a silyl ether with TIPSOTf and treatment with oxalyl chloride followed by NaOMe
32. Demopoulos V.J. Synth. Commun. 19:1989;2585